Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 5.24
- Piotroski Score 7.00
- Grade Buy
- Symbol (HRMY)
- Company Harmony Biosciences Holdings, Inc.
- Price $33.41
- Changes Percentage (1.09%)
- Change $0.36
- Day Low $32.42
- Day High $33.58
- Year High $41.61
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/19/2025
- Fiscal Year End N/A
- Average Stock Price Target $52.00
- High Stock Price Target $61.00
- Low Stock Price Target $28.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.32
- Trailing P/E Ratio 13.15
- Forward P/E Ratio 13.15
- P/E Growth 13.15
- Net Income $128.85 M
Income Statement
Quarterly
Annual
Latest News of HRMY
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript
Harmony Biosciences discussed their strong pipeline progress and revenue growth in the Q3 conference call. The company is focused on developing innovative treatments for patients with unmet medical ne...
By Yahoo! Finance | 1 week ago -
Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving Technical Ratings According To Piper Sandler?
The list of Piper Sandler's Top Technical Stock Picks includes Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY), ranking 17th with improving technical ratings. Market shifts reflect optimism after eco...
By Yahoo! Finance | 3 weeks ago -
Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts?
An article discusses the market response to the recent Federal Reserve rate cuts and insights from Tom Lee on market behavior pre-election. It also highlights Harmony Biosciences as a cheap growth sto...
By Yahoo! Finance | 1 month ago
